An Open-Label, Randomized, Single Dose, Two-Way Crossover Pilot Study to Evaluate the Relative Bioavailability of One Amlodipine 5 mg Tablet and One Enalapril Maleate 20mg Tablet to a Fixed Dose Combination Tablet Formulation of Amlodipine (5 mg) and Enalapril Maleate (20 mg), in Healthy Adult Male and Female Subjects Under Fasting Conditions
Latest Information Update: 05 Sep 2023
At a glance
- Drugs Amlodipine/enalapril (Primary) ; Amlodipine; Enalapril
- Indications Hypertension
- Focus Pharmacokinetics
- Sponsors GlaxoSmithKline; GSK
- 01 May 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Apr 2013 New trial record